Physician profile
Anub John
NPI 1184988933
$10,513.99
in general payments reported to CMS, 2019-2025
34 companies · $622 in 2025
The $622 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,230 · 2020: $159 · 2021: $124 · 2022: $811 · 2023: $1,142 · 2024: $1,427 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,682 · Food and Beverage: $1,509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,681.62 |
| Food and Beverage | $1,508.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,515.41 | 2019-2024 | Perclose Prostyle, Amplatzer Talisman, Cardiomems |
| Boston Scientific Corporation | $2,185.09 | 2022-2024 | Versacross Access Solution, Watchman Access System, Watchman |
| Edwards Lifesciences Corporation | $1,244.53 | 2019 | |
| Medtronic Vascular, INC. | $1,072.63 | 2019 | |
| Cardiovascular Systems INC. | $242.98 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $227.07 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $218.55 | 2019-2024 | |
| Chiesi USA, INC. | $180.03 | 2019 | |
| Penumbra, INC. | $178.74 | 2022-2024 | Indigo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.50 | 2019-2025 | Jardiance |
| Pfizer INC. | $128.86 | 2024-2025 | |
| Medtronic, INC. | $128.39 | 2022-2025 | Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $116.77 | 2022-2025 | Camzyos, Eliquis |
| Amgen INC. | $115.97 | 2019-2025 | Repatha, Repatha |
| Heartflow, INC. | $102.38 | 2024-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $100.58 | 2019-2021 | |
| Abiomed | $86.38 | 2025 | |
| Bridgebio Pharma, INC. | $64.50 | 2025 | Attruby |
| Actelion Pharmaceuticals US, INC. | $55.55 | 2022 | |
| Novo Nordisk INC | $46.47 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Philips North America LLC | $38.94 | 2019-2025 | Dose Professional Services |
| Siemens Medical Solutions USA, INC. | $36.09 | 2023 | Somatom X.Cite, Atellica Ch 930 Analyzer |
| Bayer Healthcare Pharmaceuticals INC. | $32.99 | 2023-2025 | |
| Angiodynamics, INC. | $32.98 | 2023-2024 | Alphavac, Angiovac |
| Biosense Webster, INC. | $32.68 | 2023 | Soundstar, Na, Carto 3 |
| Astrazeneca Pharmaceuticals Lp | $27.79 | 2022-2023 | Farxiga |
| Teleflex LLC | $25.13 | 2025 | Guideliner |
| Vifor Pharma, INC. | $24.37 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $23.92 | 2023 | Gore Cardioform Septal Occluder |
| Alnylam Pharmaceuticals INC. | $20.81 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.07 | 2022-2024 | Lifevest |
| Inspire Medical Systems, INC. | $17.31 | 2025 | Inspire |
| Terumo Medical Corporation | $15.78 | 2024 | Glidesheath Slender |
| Scpharmaceuticals INC. | $13.75 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anub John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.